| abstract |
The present invention relates to compounds of formula (I), or stereoisomers, tautomers or pharmaceutically acceptable salts thereof, compositions comprising said compounds, and cancers, immune diseases, blood loss diseases, viral infections, inflammation, metabolic / endocrine functions A method of using said compound for the treatment of a disease or disorder mediated by the p110 delta isoform of PI3 kinase, selected from disorders and neurological disorders. (I) In this formula, R 1 , R 2 , R 3 , R 4 and n are as defined herein. |